DaVita Inc

US

DVA

Health Care

132.52 ₽

Current price

Sell
132.52 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    146 / 302

  • Position in country

    5084 / 14179

  • Return on Assets, %

    5.6

    0.1

  • Net income margin, %

    7.3

    0.6

  • EBITDA margin, %

    21.5

    8.9

  • Debt to Equity, %

    794.5

    34.4

  • Intangible assets and goodwill, %

    43.3

    15.8

  • Revenue CAGR 3Y, %

    1.6

    11.7

  • Total Equity change 1Y, %

    48.2

    0

  • Revenue Y, % chg

    4.5

    1.8

  • P/E

    17.6

    25.7

  • P/BV

    10.9

    1.2

  • P/S

    0.9

    1.2

  • EV/S

    1.7

    1.5

  • EV/EBITDA

    8.4

    6.9

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    3.5

    45.6

  • Forward P/E

    14

    17.8

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    0

    18.7

Get an analytical review of this company

Competitors

Ranks

  • CorVel Corp

    00%

  • Signify Health Inc

    00%

  • Cigna Group

    00%

  • CVS Health Corp

    00%

  • Option Care Health Inc

    00%

  • Oak Street Health Inc

    00%

  • DaVita Inc

    00%

  • Chemed Corp

    00%

  • Quest Diagnostics Inc

    00%

  • Laboratory Corporation of America Holdings

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Providers & Services

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    11437.8

  • Ticker

    DVA.N

  • ISIN

    US23918K1088

  • IPO date

    1995-10-31

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-14

  • Date fact. publication of reports

    2023-12-31

Company Description

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.